Soluble receptors in human disease

被引:147
作者
Heaney, ML
Golde, DW
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Program Mol Therapeut, New York, NY 10021 USA
关键词
diagnosis; therapy; inhibitor; agonist; hormone; cytokine;
D O I
10.1002/jlb.64.2.135
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Soluble cytokine receptors naturally arise from genes encoding membrane-bound receptors or are direct derivatives of the receptors themselves. There is mounting evidence that soluble receptors play important roles in human disease states. In many cases, soluble receptors appear to play an integral part in the dynamic interaction between ligands and their membrane-bound receptors in maintaining and restoring health after a pathological insult but, in some instances, dysregulated expression of soluble receptors can contribute to disease pathology, Nonetheless, an appreciation of the biological actions of soluble receptors, particularly as cytokine inhibitors, has led to their therapeutic use in human diseases, Although early clinical trials of soluble receptors have had unexpected toxicities, their application in medicine continues to advance and. it is likely that soluble receptors will join hormones, cytokines, and growth factors as established biological therapies.
引用
收藏
页码:135 / 146
页数:12
相关论文
共 188 条
[1]   IDENTIFICATION OF MESSENGER-RNAS ENCODING 2 DIFFERENT SOLUBLE FORMS OF THE HUMAN INTERFERON ALPHA-RECEPTOR [J].
ABRAMOVICH, C ;
RATOVITSKI, E ;
LUNDGREN, E ;
REVEL, M .
FEBS LETTERS, 1994, 338 (03) :295-300
[2]   STABILIZATION OF THE BIOACTIVITY OF TUMOR-NECROSIS-FACTOR BY ITS SOLUBLE RECEPTORS [J].
ADERKA, D ;
ENGELMANN, H ;
MAOR, Y ;
BRAKEBUSCH, C ;
WALLACH, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :323-329
[3]   A mechanism for the inhibition of fever by a virus [J].
Alcami, A ;
Smith, GL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :11029-11034
[4]  
ALCAMI A, 1995, J VIROL, V69, P4633
[5]   A SOLUBLE RECEPTOR FOR INTERLEUKIN-1-BETA ENCODED BY VACCINIA VIRUS - A NOVEL MECHANISM OF VIRUS MODULATION OF THE HOST RESPONSE TO INFECTION [J].
ALCAMI, A ;
SMITH, GL .
CELL, 1992, 71 (01) :153-167
[6]   SOLUBLE INTERLEUKIN-2 RECEPTOR IN HAIRY-CELL LEUKEMIA - A RELIABLE MARKER OF DISEASE [J].
AMBROSETTI, A ;
NADALI, G ;
VINANTE, F ;
RICETTI, MM ;
TODESCHINI, G ;
MOROSATO, L ;
DESABATA, D ;
ANDREIS, IAB ;
CHILOSI, M ;
SEMENZATO, G ;
PIZZOLO, G .
INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1993, 23 (01) :34-37
[7]   THE EFFECT OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR-II ON ENDOTOXIN-MEDIATED HEMODYNAMIC INSTABILITY [J].
ANDERSON, JA ;
KNOTT, AW ;
WILSON, MA ;
GARRISON, RN ;
SIMS, DE ;
EDWARDS, MJ .
JOURNAL OF SURGICAL RESEARCH, 1995, 58 (01) :53-57
[8]  
Arend W P, 1995, Adv Intern Med, V40, P365
[9]  
AREND WP, 1994, J IMMUNOL, V153, P4766
[10]   PROTECTION AGAINST ENDOTOXIC-SHOCK BY A TUMOR-NECROSIS-FACTOR RECEPTOR IMMUNOADHESIN [J].
ASHKENAZI, A ;
MARSTERS, SA ;
CAPON, DJ ;
CHAMOW, SM ;
FIGARI, IS ;
PENNICA, D ;
GOEDDEL, DV ;
PALLADINO, MA ;
SMITH, DH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10535-10539